Jul 15, 2026Board meeting
Board Of Pharmacy Board Meeting
The board meeting covered several regulatory and administrative topics. Key discussions included the current FDA stance on compounding peptides, with a focus on which peptides are permissible for compounding and the requirement for pharmacists to adhere to United States Pharmacopeia (USP) standards as mandated by federal law. The board also received a treasurer's report detailing the fiscal year's revenue and operating expenses, as well as a wellness committee report regarding monitoring of health professionals.